Applying Data Mining Techniques for Predicting Prognosis in Patients with Rheumatoid Arthritis

Area of Science:

• Rheumatoid arthritis (RA) research
• Medical data mining and machine learning applications

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease with unclear mechanisms, potentially involving autoimmune issues, genetics, and infections.
• Current RA treatment selection and adjustments are based on disease activity but can lead to uncertain outcomes and reduced healthcare quality.

Purpose of the Study:

• To develop and evaluate data mining classifiers for predicting rheumatoid arthritis (RA) prognosis.
• To analyze the likelihood of erythrocyte sedimentation rates (ESR) remaining within normal ranges under different medication strategies for RA patients.
• To identify the most effective prediction model for assisting clinical decision-making in early-stage RA.

Main Methods:

• Combined expert opinions with data mining techniques to construct predictive classifiers.
• Utilized clinical data to train and evaluate models including Logistic Regression, Support Vector Machines (SVM), and Decision Trees (DT).
• Employed gain ratio analysis to determine the importance of various factors in prediction rules.

Main Results:

• The Decision Tree (DT) model achieved the highest prediction accuracy (0.9094) for predicting ESR within normal ranges in RA patients.
• For the RA complications dataset, the DT model demonstrated superior accuracy (0.9812) compared to Logistic Regression (0.9393) and SVM (0.9290).
• Gain ratio analysis identified key factors influencing RA prognosis prediction.

Conclusions:

• Data mining models, particularly Decision Trees, show significant potential for accurately predicting rheumatoid arthritis (RA) prognosis.
• The developed prediction models can aid in formulating clinical treatment guidelines and implementing decision support systems for early RA management.
• Accurate prognosis prediction can assist healthcare professionals in making timely and effective treatment decisions for RA patients.